Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0677 after hip fracture repair in patients with sarcopenia
2005-002509-22Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Sarcopenia comparing MK-0677 with Placebo (2 arms). Primary endpoint: Change from baseline in PFP-10 total score at Week 24. Started Jul 2005; status: terminated.
02
Drugs
ibutamoren
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on 2005-002509-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002509-22.